• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与左心室舒张功能超声心动图参数:系统评价和荟萃分析。

Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis.

机构信息

3rd Department of Cardiology, Sotiria Chest Disease Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

1st Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

出版信息

Int J Mol Sci. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292.

DOI:10.3390/ijms241814292
PMID:37762592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10532416/
Abstract

The cardiovascular implications of non-alcoholic fatty liver disease (NAFLD) have been associated with heart failure with preserved ejection fraction (HFpEF). The purpose of this review was to conduct a bibliographic search regarding the correlation between NAFLD and the echocardiographic parameters of left ventricular diastolic function. A systematic literature search was conducted in PubMed and Embase for original research data reporting on the association of NAFLD with diastolic function markers [E/e', left atrial volume index (LAVi), left ventricular mass index (LVMi)]. Meta-analysis was performed using the meta and dmetar packages in R studio v.1.4.1106, with < 0.05 values being considered significant. Results are expressed as the standardized mean difference (SMD) for continuous variables and as the odds ratio (OR) for categorical variables, with respective 95% confidence intervals (CI). Heterogeneity between studies was expressed with index Ι. From the preliminary search, 2619 articles were found from which 31 studies were included in the final statistical analysis. The meta-analysis of 8 studies which reported on the prevalence of diastolic dysfunction showed that it was increased in patients with NAFLD (OR: 2.07, 95% CI 1.24-3.44 with = 0.01, I: 80% with < 0.01). The meta-analysis of 21 studies showed significantly higher E/e' in NAFLD patients (SMD 1.02, 95% CI 0.43-1.61 with < 0.001, I: 97% with < 0.001). Individuals with NAFLD had increased LAVi (SMD: 0.87, 95% CI 0.38-1.37 with < 0.001, I: 96% with < 0.001) and LVMi (SMD: 0.89, 95% CI 0.31-1.48 with = 0.003, I: 100% with < 0.001). To conclude, in the meta-analysis of 31 observational studies, NAFLD patients were found to have affected left ventricular diastolic function, supporting the hypothesis of NAFLD being associated with HFpEF.

摘要

非酒精性脂肪肝(NAFLD)与心力衰竭射血分数保留型(HFpEF)的心血管影响有关。本综述的目的是对非酒精性脂肪肝与左心室舒张功能的超声心动图参数之间相关性进行文献检索。在 PubMed 和 Embase 中进行了系统的文献检索,以获取报告非酒精性脂肪肝与舒张功能标志物[E/e'、左心房容积指数(LAVi)、左心室质量指数(LVMi)]相关性的原始研究数据。使用 R studio v.1.4.1106 中的 meta 和 dmetar 包进行荟萃分析, < 0.05 被认为具有统计学意义。结果以连续变量的标准化均数差(SMD)和分类变量的比值比(OR)表示,各自的 95%置信区间(CI)。研究间的异质性用指数 Ι 表示。从初步检索中,共找到 2619 篇文章,其中 31 篇研究纳入最终的统计分析。对 8 项报告舒张功能障碍患病率的研究进行荟萃分析显示,NAFLD 患者的舒张功能障碍患病率增加(OR:2.07,95%CI 1.24-3.44, = 0.01,I:80%, < 0.01)。对 21 项研究进行荟萃分析显示,NAFLD 患者的 E/e'显著升高(SMD 1.02,95%CI 0.43-1.61, < 0.001,I:97%, < 0.001)。NAFLD 患者的左心房容积指数(LAVi)增加(SMD:0.87,95%CI 0.38-1.37, < 0.001,I:96%, < 0.001)和左心室质量指数(LVMi)增加(SMD:0.89,95%CI 0.31-1.48, = 0.003,I:100%, < 0.001)。总之,在 31 项观察性研究的荟萃分析中,发现 NAFLD 患者的左心室舒张功能受到影响,支持非酒精性脂肪肝与 HFpEF 相关的假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/4617687c41c8/ijms-24-14292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/b87f4d9620d0/ijms-24-14292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/b117ae915f32/ijms-24-14292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/4617687c41c8/ijms-24-14292-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/b87f4d9620d0/ijms-24-14292-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/b117ae915f32/ijms-24-14292-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bab4/10532416/4617687c41c8/ijms-24-14292-g003.jpg

相似文献

1
Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病与左心室舒张功能超声心动图参数:系统评价和荟萃分析。
Int J Mol Sci. 2023 Sep 19;24(18):14292. doi: 10.3390/ijms241814292.
2
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
3
Erectile Dysfunction Is Associated with Left Ventricular Diastolic Dysfunction: A Systematic Review and Meta-analysis.勃起功能障碍与左心室舒张功能障碍相关:系统评价和荟萃分析。
Eur Urol Focus. 2023 Nov;9(6):903-912. doi: 10.1016/j.euf.2023.06.001. Epub 2023 Jun 22.
4
Glucocorticosteroids for people with alcoholic hepatitis.用于酒精性肝炎患者的糖皮质激素。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD001511. doi: 10.1002/14651858.CD001511.pub3.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Efficacy of statins in treatment and development of non-alcoholic fatty liver disease and steatohepatitis: A systematic review and meta-analysis.他汀类药物在治疗和发展非酒精性脂肪性肝病和脂肪性肝炎中的疗效:系统评价和荟萃分析。
Clin Res Hepatol Gastroenterol. 2022 Apr;46(4):101816. doi: 10.1016/j.clinre.2021.101816. Epub 2021 Oct 2.
8
Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD): an attempted network meta-analysis.非酒精性脂肪性肝病(NAFLD)的药物干预:一项网状Meta分析尝试
Cochrane Database Syst Rev. 2017 Mar 30;3(3):CD011640. doi: 10.1002/14651858.CD011640.pub2.
9
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。
Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.

引用本文的文献

1
Decoding the Liver-Heart Axis in Cardiometabolic Diseases.解读心脏代谢疾病中的肝心轴
Circ Res. 2025 May 23;136(11):1335-1362. doi: 10.1161/CIRCRESAHA.125.325492. Epub 2025 May 22.
2
Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes.2型糖尿病患者中代谢功能障碍相关脂肪性肝病相关纤维化及心脏功能障碍
World J Cardiol. 2024 Oct 26;16(10):580-594. doi: 10.4330/wjc.v16.i10.580.
3
Impairment in Right Ventricular-Pulmonary Arterial Coupling in Overweight and Obesity.

本文引用的文献

1
Molecular Mechanisms and Therapeutic Implications of Endothelial Dysfunction in Patients with Heart Failure.心力衰竭患者内皮功能障碍的分子机制及治疗意义。
Int J Mol Sci. 2023 Feb 21;24(5):4321. doi: 10.3390/ijms24054321.
2
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis.非酒精性脂肪性肝病是否是 2 型糖尿病患者左心室舒张功能障碍的标志?系统评价和荟萃分析。
BMJ Open Diabetes Res Care. 2023 Feb;11(1). doi: 10.1136/bmjdrc-2022-003198.
3
Non-alcoholic fatty liver disease: Definition and subtypes.
超重和肥胖人群右心室-肺动脉耦合功能受损
J Clin Med. 2024 Jun 10;13(12):3389. doi: 10.3390/jcm13123389.
4
Longitudinal Variations in Th and Treg Cells Before and After Percutaneous Coronary Intervention, and Their Intercorrelations and Prognostic Value in Acute Syndrome Patients.经皮冠状动脉介入治疗前后Th细胞和调节性T细胞的纵向变化及其在急性综合征患者中的相互关系和预后价值
Inflammation. 2025 Feb;48(1):316-330. doi: 10.1007/s10753-024-02062-x. Epub 2024 Jun 14.
非酒精性脂肪性肝病:定义和亚型。
Clin Mol Hepatol. 2023 Feb;29(suppl):S5-S16. doi: 10.3350/cmh.2022.0424. Epub 2022 Dec 28.
4
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis.非酒精性脂肪性肝炎及其纤维化的发病机制与治疗。
Clin Mol Hepatol. 2023 Jan;29(1):77-98. doi: 10.3350/cmh.2022.0237. Epub 2022 Oct 13.
5
Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology.代谢相关脂肪性肝病与左心室舒张功能和心脏形态的相关性。
Front Endocrinol (Lausanne). 2022 Jul 19;13:935390. doi: 10.3389/fendo.2022.935390. eCollection 2022.
6
Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.非酒精性脂肪性肝病中的内皮功能障碍:一项系统评价和荟萃分析。
Life (Basel). 2022 May 11;12(5):718. doi: 10.3390/life12050718.
7
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease.炎症细胞因子与非酒精性脂肪性肝病的关系。
Front Immunol. 2022 May 6;13:880298. doi: 10.3389/fimmu.2022.880298. eCollection 2022.
8
Association of Non-Alcoholic Fatty Liver Disease and Hepatic Fibrosis with Epicardial Adipose Tissue Volume and Atrial Deformation Mechanics in a Large Asian Population Free from Clinical Heart Failure.在一个无临床心力衰竭的大型亚洲人群中,非酒精性脂肪性肝病和肝纤维化与心外膜脂肪组织体积及心房变形力学的关联
Diagnostics (Basel). 2022 Apr 6;12(4):916. doi: 10.3390/diagnostics12040916.
9
Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis.非酒精性脂肪性肝病与结构性心脏、收缩和舒张功能障碍的关联:一项荟萃分析。
Hepatol Int. 2022 Apr;16(2):269-281. doi: 10.1007/s12072-022-10319-6. Epub 2022 Mar 23.
10
Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.肝脏硬度测量可在无明显心脏疾病的非进展期非酒精性脂肪性肝病患者中识别亚临床心肌功能障碍。
Intern Emerg Med. 2022 Aug;17(5):1425-1438. doi: 10.1007/s11739-022-02966-2. Epub 2022 Mar 17.